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Abstract: Medullary thyroid carcinoma (MTC), a neuroendocrine tumor arising from the 
thyroid gland, is known to be poorly responsive to conventional chemotherapy. The root of 
Stemona tuberosa Lour, also called Bai Bu, is a commonly used traditional Chinese anti-
tussive medicine. The present study investigated this medicinal herb for the ﬁ  rst time with 
respect to its anticancer activity in human medullary thyroid carcinoma cells. Four extracts 
of Stemona tuberosa Lour, including the n-hexane fraction, (ST-1), dichloromethane (DCM) 
fraction, (ST-2), ethyl acetate (EtOAc) fraction, (ST-3), and methanol fraction, (ST-4) were 
examined for antiproliferative effects in two MTC cell lines. We observed that only the DCM 
fraction ST-2 inhibited cell growth and viability in a dose-dependent manner. Furthermore, 
we found that ST-2 also induced the apoptosis of MTC-SK cells. Caspase-3/7 was activated, 
while caspase-9 was not, implying that at least a caspase-dependent apoptotic pathway was 
involved in this process. In addition, the multicellular spheroids of MTC-SK were destroyed 
and the cell morphology was changed by ST-2. Our results show the strong apoptotic effects 
of the DCM fraction of Stemona tuberosa Lour on human medullary thyroid carcinomas, 
so suggesting a new candidate for chemotherapy of the so far chemo-resistant medullary 
thyroid carcinoma.
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Introduction
Human medullary thyroid carcinoma (MTC), a malignant neoplasm derived from 
parafollicular cells, represents about 5%–10% of thyroid tumors (Vitale et al 2001). 
It may occur sporadically, in a familial form without associated endocrinopathies, 
or combined with other endocrinopathies as multiple endocrine neoplasia type 2A 
or 2B with autosomal dominant inheritance (Eng et al 1996). The clinical course of 
patients with MTC is variable, ranging from indolent to extremely aggressive, and it 
is related to the stage of the disease. At present, the primary treatment of MTC is the 
surgical removal of all neoplastic tissue. Non-surgical approaches to MTC treatment 
have met with inconsistent results. Chemotherapy generally is used in patients with 
rapidly progressive, measurable, metastatic disease. To date, none of the regimens 
reported has been found to be particularly effective, and the response rate has been 
generally low (Orlandi et al 2001).
Oriental medicinal herbs with anticancer activity are currently in the spotlight as a 
complementary or alternative medicine. The root of Stemona tuberosa Lour is a traditional 
Chinese medicinal plant known for its antitussive and anti-ectoparasitic activity (Lee and Biologics: Targets & Therapy 2007:1(4) 456
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Chiang 1994; Chung et al 2003). Alkaloids, stilbenoides, and 
tocopherols have been identiﬁ  ed as main constituents of the 
plant (Li et al 2007; Schinner et al 2007). Recently, S. tuberosa 
extracts have been attracting new interest for their multi-
biological functions including anti-tuberculotic, antifungal, 
demulcent and anticancer activity (Rinner et al 2004; Greger 
2006). In our previous work we report for the ﬁ  rst time that S. 
stemona whole extract, provided by Prof. H. Greger, Institute 
of Botany, University of Vienna, Austria (Greger 2006; Li 
2007), had apoptotic effects on a human medullary thyroid 
carcinoma cell line, GSJO (Rinner et al 2004). Nevertheless, 
the anticancer activity of this plant, including cell growth 
inhibition, changes in aggregation, and in the pathways of 
apoptosis, required further investigations.
In this study we aimed to test the chemosensitivity and 
potential mechanisms of action of Stemona tuberosa Lour 
in chemo-resistant tumor cells. From S. tuberosa n-hexane, 
dichloromethane, ethyl acetate and methanol extracts were 
successively obtained and tested for their anticancer activity 
in two human medullary thyroid carcinoma cell lines and one 
human ﬁ  broblast cell line.
Materials and methods
Plant extraction
The roots of Stemona tuberosa Lour were provided by Prof. 
Tran Hung, Faculty of Pharmacy, University of Medicine 
and Pharmacy at Ho Chi Minh City, Vietnam. A voucher 
specimen (IBK-SST-Sttu 1) is deposited at the Institute of 
Pharmacy/Pharmacognosy at the University of Innsbruck. 
The ground plant material was consecutively extracted in 
a Soxhlet apparatus by n-hexane, (ST-1), DCM, (ST-2), 
EtOAc, (ST-3), and methanol, (ST-4). The solvents were 
evaporated under reduced pressure. Aliquots of 10 mg were 
dissolved in 1 ml of dimethyl sulphoxide (DMSO, Sigma, 
Vienna, Austria) and stored at −20 °C.
Reagents
Acetic acid (p.A. quality), acetonitrile (gradient grade), 
EtOAc, n-hexane, DCM and methanol (all p.A. quality) 
were purchased from Merck (Darmstadt, Germany). Water 
was produced by reverse osmosis followed by distillation, 
nitrogen (99.995%) for mass spectrometry experiments was 
produced by a nitrogen generator (Peak Scientiﬁ  c Instruments 
Ltd., Fountain Crescent, UK).
HPLC-MS instrumentation
HPLC was performed using a HP 1100 Liquid Chromatograph 
(Agilent Technologies, Waldbronn, Germany) equipped 
with a G1311A quaternary pump, a G1315B diode array 
detector (DAD), a G1313A automatic injector and auto 
sampler, a G1316A column oven, a G1322A vacuum 
degasser. The system was controlled by ChemStation 
software (version 9.01).
The HPLC was coupled to an Esquire 3000plus ion-trap 
mass spectrometer (Bruker Daltonics, Bremen, Germany) 
using an Electrospray ionization source, the system was 
controlled by Bruker Daltonics Esquire software 5.0.
HPLC–DAD-MS conditions
Separations were done on a Phenomenex Synergi Polar RP 
column (150 × 4.6 mm, 4 μm particle size, Phenomenex. 
Torrence, USA) with a solvent gradient of water (A) and 
acetonitril (C), both with 0.1% acetic acid. The Phenomenex 
SecurityGuard system equipped with a Synergi Polar RP 
cartridge (4 mm × 2 mm) was used as guard column. Gra-
dient: t = 0 min 65% A; t = 10 min 50% A; t = 20 min 2% 
A. Between runs the column was equilibrated with 65% 
A for 10 min. The system was operated at a ﬂ  ow rate of 
1 ml/min at 25 °C. The injection volume was 10 μl. DAD 
derived chromatograms were recorded at 210, 270, 295 
and 300 nm. A static 1:5 splitter was used to hyphenate 
the HPLC device to an Esquire 3000plus ion-trap mass 
spectrometer (Bruker Daltonics, Bremen, Germany). Mass 
spectrometry experiments were performed in alternating 
ESI-mode with a spray voltage of 4500 V; N2 at 3.5 bar 
as sheath gas and N2 at 10 l/min, 350 °C as dry gas. Mass 
spectra were recorded over the range 100–1500 m/z. The 
Bruker ion-trap mass spectrometer was operated under an 
ion current control (ICC) of approximately 50,000 with 
a max accumulation time of 20 ms. For HPLC-DAD-MS 
analysis aliquots of 10 mg ST-1 – ST-4 were dissolved in 
1 ml methanol and ﬁ  ltered through a 0.45 μm ﬁ  lter (PET, 
Machery-Nagel, Düren, Germany).
Cell lines and cell culture
The human medullary thyroid carcinoma cell lines MTC-
SK (Pfragner et al 1990), SINJ (Pfragner et al 1993) 
and the normal human skin ﬁ  broblast cell line, HF-SAR 
were established in our laboratory. The MTC-cells were 
maintained in Ham’s F-12: M199 medium (1:1; Biowhit-
taker, Verviers, Belgium) containing 10% fetal bovine 
serum (PAA Laboratories, Pasching, Austria) at 37 °C, 
in an atmosphere of 5% CO2. HF-SAR ﬁ  broblasts were 
cultured in MEM-E medium, supplemented with 10% 
fetal bovine serum, at 37 °C, 5% CO2. All cell lines were 
mycoplasma – free.Biologics: Targets & Therapy 2007:1(4) 457
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Cell counting
MTC-SK and SINJ cells were seeded at a density of 2 × 105 
cells/ml into 24-well plates (Sarstedt, Wiener Neudorf, 
Austria) and incubated for 24 and 48 h in completed medium 
with DMSO (control) or supplemented with 50 μg/ml of each 
extract. Cells were counted after pipetting the cell clusters 
into single cells, and cell numbers were determined with an 
automated cell counter (Casy-1Cell Counter and Analyzer, 
Schärfe System, Reutlingen, Germany). Each sample was 
measured in triplicate. The mean value and S.D. were 
calculated automatically by the cell counter.
WST-1 cell viability assay
Cell proliferation and viability were quantiﬁ  ed using the 
WST-1 cell proliferation reagent (4-[3-(4-iodophenyl)-
2-(4-nitrophenyl)-2H-5-tetrazolio]-1, 3-benzene 
disulphonate) (Roche Diagnostics, Vienna, Austria) 
according to the manufacturer's protocol. This method is 
based on the ability of viable cells to metabolize tetrazolium 
salt WST-1 to formazan by mitochondrial dehydrogenases. 
MTC-SK and SINJ suspension cells were seeded at a density 
of 2 × 105 cells/ml in 24-well plates (Sarstedt, Wiener 
Neudorf, Austria). After 24, 48 or 72 h treatment with 
different concentrations of solvent extracts or DMSO, cells 
were pipetted carefully into single cells and transferred into 
96-well plates; then 10 μl WST-1 labeling mixture per well 
was added. After incubation at 37 °C for 2 hours, the samples 
were quantiﬁ  ed spectrophotometrically by measuring the 
absorbance of the formazan product at 450 nm with an ELISA 
plate reader. For HF-SAR adherent cells, cells were seeded 
directly into 96-well plates at a density of 1 × 105 cells/ml. 
After the adherence to plates, cells were treated with extracts 
for 24, 48 and 72 h and measured as above. Each sample was 
tested for 6 parallels; means and S.D. were calculated.
TUNEL assay
Cells were detected using the In Situ Cell Death Detection Kit, 
Fluorescein (Roche, Lewes, UK cat  # 11684795910) according 
to manufacturer’s instructions. Brieﬂ  y, cells were treated with 
ST-2 for 24 h, washed with PBSA, and harvested. The cells 
were ﬁ  xed with freshly prepared 4% paraformaldehyde for 
60 min at room temperature and treated with 0.1% Triton 
X-100 solution for 2 min on ice. Intracellular DNA fragments 
were then labeled by exposing the cells to TUNEL reaction 
mixture for 1 h at 37 °C, in a humidiﬁ  ed atmosphere and 
protected from light. The cells were washed with PBSA twice, 
then transferred to slides and analyzed under a ﬂ  uorescence 
microscope (Nikon eclipse TE300, Tokyo, Japan).
Caspase 3/7 activity, caspase 9 activity, 
and ATP luminescent cell viability assay
Caspase 3/7, caspase 9 and cell viability activity were 
measured in one sample by using three homogenous, 
luminescent assay kits (Promega, Madison, WI, USA, 
cat # G8091, cat # G8211, and cat # G7570, respectively) 
according to the manufacturer’s instructions. Briefly, 
1 ml MTC-SK cells were seeded into 24-well plates at a 
density of 2 × 105 cells/ml and incubated in completed 
Ham’s F-12: M199 medium with 25 μg/ml, 50 μg/ml, or 
100 μg/ml ST-2, 5 mM CPT positive control, or 5 μl DMSO 
negative control for 4 h at 37 °C. After pipetting thoroughly 
into single cells, each sample was transferred into three 
96-well white-walled plates (Nunc, Roskilde, Denmark) 
and measured separately for its caspase 3/7, caspase 9 and 
cell viability activity. The luminescence of each sample 
was measured with a plate-reading luminometer (Mediators 
PhL, Mediators Diagnostika, Vienna, Austria) as directed 
by the manufacturer of the instrument. Each treatment was 
measured for 3 parallel samples, and mean value and S.D. 
were calculated. Next, we investigated whether an inhibition 
of caspases inhibited apoptosis in MTC-SK cells. MTC-SK 
cells were seeded into microplates. One group was treated 
with 25 μg/ml, 50 μg/ml or 100 μg/ml ST-2, or 5 μl DMSO 
negative control, as described above. Another group was 
co-treated with 50 μM of the speciﬁ  c caspase-3 inhibitor Ac-
DEVD-CHO (Promega, Madison , WI, USA, cat # G5961). 
After 36 h and 72 h the cell numbers were counted by Casy-1 
Cell Counter and Analyzer. Cell proliferation and viability 
were determined by the WSt-1 cell proliferation assay.
Results
HPLC-DAD-MS Analysis of the Stemona 
extracts (ST-1 – ST-4)
The extracts ST-1 – ST-4 were analyzed by HPLC-DAD-MS, 
the resulting HPLC-DAD chromatograms are shown in Figure 
1. Particularly two classes of compounds seem to be of interest 
considering their published activities, namely pyrrolo- or 
pyridoazepine alkaloids and stilbenoids (Pacher et al 2002; Greger 
2006). Whereas alkaloids as croomine and tuberostemonine 
derivatives were present (not visible in the UV traces) in all four 
extracts (Rt 4–8 min), no stilbenoids could be detected by UV or 
MS. In ST-1 and ST-2 fatty acids and phytosterols were visible 
in the MS chromatograms as side compounds. However, none 
of the prominent HPLC-peaks was elucidated in this preliminary 
analysis. The phytochemical investigation of the most active 
extract ST-2 is an ongoing project.Biologics: Targets & Therapy 2007:1(4) 458
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Effects of Stemona tuberosa Lour on 
cell growth of MTC-SK cells
S. tuberosa n-hexane, DCM, EtOAc and methanol fractions 
were evaluated by cell counting for their ability to inhibit 
growth and proliferation in the MTC-SK cell line. MTC-SK 
cells were seeded at a density of 2.26 × 105 cells/ml and incu-
bated for 48 h in completed medium with DMSO (control) or 
supplemented with 100 μg/ml of each fraction, then the cells 
were counted with an automated cell counter. After 48 h treat-
ment with ST-2, the numbers of total viable MTC-SK cells 
were 2.31×105 cells/ml, which were signiﬁ  cantly lower than 
those treated by DMSO or other fractions, which were 3.86 × 
105 cells/ml by DMSO, 3.7 × 105 cells/ ml by ST-1, 3.68 × 105 
cells/ml by ST-3, 4.03 × 105 cells/ ml by ST-4 (t-test p   0.01) 
(Figure 2A). The data obtained showed that only the dichlo-
romethane fraction, ST-2, induced a signiﬁ  cant inhibition of 
growth and proliferation at the concentration of 100 μg/ml in 
the MTC-SK cells. On the contrary, the n-hexane, EtOAc, and 
MeOH fractions had no antiproliferative activity at levels as 
high as 100 μg/ml (Figure 2A). Moreover, treatment with ST-2 
showed growth suppression in a dose-dependent manner. This 
experiment is shown in Figure 2B. The cell numbers obtained 
by cell counting after ST-2 treatment were 4.76 × 105 cells/ml 
at 0 μg/ml, 4.07 × 105 cells/ml at 25 μg/ml, 1.8 × 105 cells/ml 
at 50 μg/ml and 1.74 × 105 cells/ml at 100 μg/ml.
Effects of Stemona tuberosa Lour 
on cell viability of MTC-SK, SINJ 
and HF-SAR cells
To further conﬁ  rm the changes in viability, we tested the 
mitochondrial dehydrogenases activity by using reagent 
WST-1. The results showed that cell viability signiﬁ  cantly 
decreased in MTC-SK cells with increasing exposure con-
centration of the ST-2 but no signiﬁ  cant effect was found 
with other ST fractions (Figure 3A).
To study generalized applicability of Stemona tuberosa 
Lour, we tested its effects on another human medullary thy-
roid carcinoma cell line, SINJ, and on normal non-cancer 
human ﬁ  broblast cells, HF-SAR. Similar to MTC-SK cells, 
the SINJ medullary thyroid carcinoma cells were also sup-
pressed by the ST-2 fraction in a dose-dependent manner. 
The HF-SAR ﬁ  broblast cell line was not inﬂ  uenced by S. 
tuberosa fractions (Figures 3B and 3C). This result revealed 
that there were sensitivity differences between cancer cells 
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Figure1 HPLC-DAD chromatograms of S-T 1 – ST-4. HPLC stationary phase: Phenomenex Synergi Polar RP column (150 × 4.6 mm, 4 μm); mobile phase: water (A) and 
acetonitrile (B) (both with 0.1% acetic acid), gradient: 65% A to 50% A in 10 min, from 50% to 2% in 10 min; ﬂ  ow rate: 1ml/min; temperature: 25 °C; injection volume: 10 μl.Biologics: Targets & Therapy 2007:1(4) 459
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and normal cells, implying that plant object is a promising 
chemotherapeutic drug.
Induction of apoptotic pathway 
by S. tuberosa DCM fraction
Since DNA nucleososomal fragmentation is the hallmark of 
apoptotic death, TUNEL DNA fragmentation analysis was 
used to detect broken DNA in the ST-2- treated MTC-SK cells. 
We observed a dose-dependent green immunoﬂ  uorescence 
that was more intensive in MTC-SK cells treated with high 
concentrations of ST-2. Control cells or MTC-SK treated with 
low concentrations of ST-2 showed only weak ﬂ  uorescence sig-
nals, suggesting that ST-2 has apoptotic activity (Figure 4A).
We also measured caspase 3/7 activation as an indicator 
of apoptosis induction since different upstream pathways 
leading to apoptosis depend on caspase 3/7 induction for 
ﬁ  nal apoptotic execution. Figure 4B shows the effects of 
different concentrations of ST-2 at the level of caspase 3/7 
induction. There was a dose-dependent increase in the cas-
pase 3/7 activity with ST-2 exposure for 4 h. Relative ratio 
days with ST-2 treatment
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Figure 2  Growth inhibition of human medullary thyroid carcinoma MTC-SK cells by ST-2. (A) MTC-SK cells were grown and treated with indicated Stemona tuberosa Lour 
fractions at the concentration of 100 μg/ml, then the number of viable cells was counted and calculated electronically by CASY-1 Cell Counter and Analyzer after 0, 24, 48 h. 
(B) MTC-SK cells were grown and treated with indicated concentration of ST-2 for 48 h. The total living cell numbers were analyzed by Cell Counter and Analyzer after 0, 24, 
48 h.  All the values represent the means ± S.D. (n = 3).Biologics: Targets & Therapy 2007:1(4) 460
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of caspase 3/7 activity was 1.42 + 0.08 at 25 μg/ml, 2.18 + 
0.03 at 50 μg/ml, and 4.56 + 0.17 at 100 μg/ml.
To conﬁ  rm whether an intrinsic pathway was involved, 
the activity of active caspase-9 was treated with ST-2 at 
concentrations of 25 μg/ml or 50 μg/ml, and decreased at 
the concentration of 100 μg/ml (Figure 4C). The decrease of 
caspase 9 may be deduced from the downregulation of the 
whole number of viable cells, as tested by ATP-luminescent 
cell viability assay using the same samples (Figure 4D).
We found that only the dichloromethane (DCM) fraction 
of ST-2 inhibited cell growth and induced apoptosis in 
MTC-SK cells. The caspase-dependent apoptotic pathway 
was involved in this process. Executor caspases 3/7 were 
activated, but initiator caspase of the intrinsic pathway 
caspase 9, was not involved in this process.
Effect of S. tuberosa DCM fraction 
on multicellular aggregation and cell 
morphology
As we reported previously (Pfragner 1990, 1993), the MTC-
SK cells originally grow as a suspension of multicellular 
MTC-SK 
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aggregates. It is believed that the ability of cell populations 
to survive in the aggregated form is a potential index for 
tumorigenicity, which might also be a reason for drug and 
radiation resistance in cancer (Olive and Durand 1994). In 
this study, as shown in Figure 5A, the multicellular tumor 
spheroids of MTC-SK cells dissociated after treatment with 
100 μg/ml ST-2 for 24 h. We also saw alteration of cell 
aggregates, signiﬁ  cant treatment-induced morphological 
changes indicative of cell death and growth inhibition in 
ST-2 treated MTC-SK cells (Figure 5A). In addition, after a 
24 h ST-2 treatment, the cell counts and cell size in MTC-SK 
decreased in comparison to the control, and the percentage 
of dead cells and cell debris increased (Figure 5B). Co-treat-
ment of MTC-SK cells with ST-2 (25 μg/ml, 50 μg/ml, 100 
μg/ml) and the speciﬁ  c caspase-3 inhibitor Ac-DEVD-CHO 
(50 μM) promoted cell survival and proliferation. While ST-2 
treatment alone induced apoptosis, the inhibitor reduced this 
effect signiﬁ  cantly (data not shown).
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Discussion
Oriental medicinal herbs are still an important source of 
promising lead compounds for the generation of antineoplastic 
drugs. In this study, as a ﬁ  rst step to provide scientiﬁ  c 
evidence for anticancer activity of Stemona tuberosa Lour, 
the ability of dichloromethane fraction of Stemona tuberosa 
Lour to inhibit cell growth through a mechanism of action 
which involving induced apoptosis in human medullary 
thyroid carcinoma cells was demonstrated. We observed that 
among tested fractions, only the DCM fraction inhibited the 
growth of MTC-SK and SINJ cells in a dose-dependent 
manner. S. tuberosa DCM showed cytotoxicity against MTC-
SK and SINJ cells with a mean LC50 value of 50 μg/ml, 
which is remarkably low. Moreover, ST-2 did not inhibit 
normal human cells at the same concentration. The different 
chemosensitivity to ST-2 DCM reaction between medullary 
thyroid carcinoma cells and normal cells suggested ST-2 as 
a promising candidate for chemotherapy.
There is accumulating evidence that naturally occurring 
compounds and many chemotherapeutic agents with 
antitumor effects can trigger the apoptosis of cancer cells. In 
agreement with this line of thought, we provide evidence that 
ST-2 induced cell death with the classic features of apoptosis. 
To further characterize the potential apoptotic signaling 
pathways activated by ST-2, a series of luminescent-
based assays were performed. We demonstrated that the 
executor caspase 3/7 was involved in the apoptosis-inducing 
mechanism. As reported (Strasser et al 2000), in the intrinsic 
mitochondrial pathway, apoptosis is triggered by pro-
apoptotic members of the bcl-2 family, leading predominantly 
to activation of the initiator caspase 9. This pathway plays 
a major role in drug-induced apoptosis (Schmitt et al 2000) 
whereas we found here that caspase 9 was not activated by 
ST-2. Together with our previous study (Rinner et al 2004) 
in which the expression of the antiapoptotic protein bcl-2 was 
not found to have changed by total ST-extracts, we assume 
Figure 5 ST-2 inﬂ  uenced the MTC-SK aggregation and morphology. (A) Cellular morphology. Upper, control MTC-SK cells, growing as a suspension of multicellular 
aggregates. Bar = 50 μ. Lower, treatment with ST-2 for 24 h. The multicellular aggregates disscociated. Bar = 50 μ. (B) Cell counts. Upper, control MTC-SK cells with a low 
percentage of dead cells and cell debris (left peak) and a mean diameter of 12.29 μm; Lower, cell counts after treatment with 100 μg/ml ST-2 for 24 h, with a high percentage 
of dead cells and cell debris (left peak) and a mean diameter of 10.83 μ.
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that ST-2 does not induce apoptosis of MTC-SK cells through 
the mitochondrial pathway.
We did not specially study the relationship between 
growth inhibition and apoptosis induction. But Figure 4 
shows the effect of treatment with the DCM fraction on apop-
totic mediators caspase 3/7 in MTC-SK. After 4h of treatment 
an increasing rate of caspase 3/7 activity was detected but 
this is not completely parallel with the decreasing rates of cell 
viability. This may be due to the fact that caspase 3 activation 
is an early-stage event in apoptosis, whereas the decrease in 
cell viability occurs later than caspase 3/7 activation. When 
the percentage of viable cells after 48 h treatment in WST-1 
assay (Figure 3A) is compared with the percentage of apop-
tosis (Figure 4B), there is a signiﬁ  cant negative correlation 
between cell viability and early-stage caspase 3 activation 
(r = −0.9908). Moreover, the speciﬁ  c caspase-3 inhibitor 
Ac-DEVD-CHO blocked the effects of ST-2. Thus, we can 
assume that in MTC-SK cells, the induction of apoptosis is 
the main mode of growth inhibition by ST-2.
Almost all conventional cytotoxic anticancer drugs are 
less effective in killing tumor cells grown as multicellular 
spheroids than in killing tumor cells grown as monolayer 
cell cultures. This “multicellular resistance” reﬂ  ects the 
relative intrinsic drug-resistant phenotype of most solid 
tumors growing in vivo and is due to factors such as limited 
drug penetration or reduced fractions of proliferating cells. 
As we reported previously (Pfragner et al 1990, 1993), both 
MTC-SK and SINJ cells grow as muticellular speroids 
which may account for the chemo-resistance of MTC. In 
this study, we found that ST-2 altered the phenotype of the 
MTC cells from originally aggregating cells towards single-
cell suspensions. Studies to see whether the disruption of 
cellular aggregation actually contributes to the growth 
inhibition by ST-2 are in progress.
In summary, our findings demonstrate the in vitro 
anticancer activity of the dichloromethane fraction of 
Stemona tuberosa Lour in medullary thyroid carcinoma cells, 
possibly suggesting a new chemotherapeutic agent for the 
treatment of medullary thyroid carcinoma.
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